Skip to main content
CELZ logo

Creative Medical Technology Holdings, Inc.

CELZNASDAQHealthcareBiotechnology

$0.74Today:- (-)1Y −77.22%

As of Oct 16, 2026 close

Market cap
$3.03M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.62$6.25
Volume (live)
-
Avg. volume (3M)
876.88K

Creative Medical Technology Holdings (CELZ) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Creative Medical Technology Holdings used $5.86M of cash in operating activities and spent $5.00 on capital expenditures. That left free cash flow of −$5.86M. It repurchased $10.00K of its own shares.

Creative Medical Technology Holdings Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Creative Medical Technology Holdings, Inc. (CELZ) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-6.00-5.49-5.29-10.1419.21-36.33-8.48-13.66-2.66
Depreciation & Amortization0.120.110.090.090.090.070.030.020.02
Deferred Income Tax0.000.000.000.000.0033.980.0011.190.35
Stock Based Compensation0.000.040.040.070.600.170.000.000.14
Change in Working Capital0.010.05-2.842.190.250.690.060.130.16
Change in Accounts Receivable0.000.000.000.000.000.010.000.000.00
Change in Inventory0.000.000.000.00-0.010.000.004.202.41
Change in Accounts Payable0.00-0.04-2.952.510.240.03-0.010.090.17
Change in Other Working Capital0.050.080.11-0.324.160.660.07-4.16-2.42
Other Operating Activities0.000.00-0.030.004.160.987.181.261.10
Net Cash from Operating Activities-5.86-5.30-8.03-7.80-2.22-0.43-1.21-1.05-0.89
Investing Activities
Capital Expenditures0.00-0.20-0.100.000.00-0.250.000.000.00
Purchases of Investments0.000.00-22.85-10.080.000.000.000.000.00
Sales/Maturities of Investments0.006.5226.400.000.000.000.000.000.00
Other Investing Activities-0.050.000.000.000.000.000.000.000.00
Net Cash from Investing Activities-0.056.323.45-10.080.00-0.250.000.000.00
Financing Activities
Debt Repayment0.000.000.000.00-5.960.691.001.340.57
Common Stock Issued7.171.630.0015.4714.760.000.000.000.10
Common Stock Repurchased-0.01-0.17-0.270.00-0.200.000.000.000.00
Other Financing Activities0.010.000.000.00-0.550.000.000.000.11
Net Cash from Financing Activities7.171.45-0.2715.4712.840.691.001.340.68
Summary
Net Change in Cash1.272.47-4.85-2.4010.630.01-0.220.29-0.21
Cash at Beginning of Period5.943.478.3210.720.100.090.300.010.22
Cash at End of Period7.215.943.478.3210.720.100.090.300.01
Free Cash Flow-5.86-5.30-8.03-7.80-2.22-0.68-1.21-1.05-0.89
Supplemental Disclosures
Interest Paid----0.010.01---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Creative Medical Technology Holdings Cash Flow

What is Creative Medical Technology Holdings's free cash flow?

Creative Medical Technology Holdings had negative free cash flow of $5.86M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$5.86M minus $5.00 of capital expenditures.

How much does Creative Medical Technology Holdings spend on capital expenditures?

Creative Medical Technology Holdings spent $5.00 on capital expenditures in fiscal 2025, compared with $200.00K a year earlier.

Does Creative Medical Technology Holdings pay dividends or buy back shares?

Yes. In fiscal 2025 Creative Medical Technology Holdings returned $10.00K in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition